A 68-year-old man presented with progressive visual acuity decline OS. Optical coherence
tomography revealed an irregular pigment epithelial detachment (PED) and a ring-like
lesion enclosed in a peaked PED (inlet) with intra- and subretinal fluid (A). Early-phase
indocyanine green angiography showed a branching vascular network (BVN) with an aneurysmal
dilation (arrowhead) at the temporal margin of the BVN (B). One month after 2 brolucizumab
intravitreal injections, complete resorption of fluid, flattening of the PED, and
disappearance of the aneurysmal dilation were observed (C, D), along with reduced
vascular density of the BVN. Brolucizumab could have a prominent role in the management
of aneurysmal type 1 neovascularization. Fig.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of OphthalmologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article Info
Publication History
Published online: October 01, 2021
Accepted:
September 7,
2021
Received in revised form:
July 13,
2021
Received:
May 17,
2021
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2021 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.
